Tapentadol results in less deterioration of gastrointestinal function and symptoms than standard opioid therapy in healthy male volunteers
| dc.contributor.author | Mark, EB | en_US |
| dc.contributor.author | Nedergaard, RB | en_US |
| dc.contributor.author | Hansen, TM | en_US |
| dc.contributor.author | Nissen, TD | en_US |
| dc.contributor.author | Frokjaer, JB | en_US |
| dc.contributor.author | Scott, SM | en_US |
| dc.contributor.author | Krogh, K | en_US |
| dc.contributor.author | Drewes, AM | en_US |
| dc.date.accessioned | 2021-06-14T13:57:13Z | |
| dc.date.available | 2021-03-09 | en_US |
| dc.date.issued | 2021-05-29 | en_US |
| dc.identifier.issn | 1350-1925 | en_US |
| dc.identifier.other | ARTN e14131 | en_US |
| dc.identifier.other | ARTN e14131 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/72504 | |
| dc.relation.ispartof | NEUROGASTROENTEROLOGY AND MOTILITY | en_US |
| dc.subject | colon | en_US |
| dc.subject | constipation | en_US |
| dc.subject | motility | en_US |
| dc.subject | opioid | en_US |
| dc.title | Tapentadol results in less deterioration of gastrointestinal function and symptoms than standard opioid therapy in healthy male volunteers | en_US |
| dc.type | Article | |
| dc.identifier.doi | 10.1111/nmo.14131 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000655927200001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
